Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    "Penile Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)
Condition: Locally-advanced or Metastatic Penile Neoplasms
Intervention: Drug: Vinflunine
2 Unknown  Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis
Conditions: Penile Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Dacomitinib
3 Not yet recruiting HOUSTON - Incidence of Oropharyngeal, Anal and Penile Cancer in Men With Antibodies to Human Papillomavirus (HPV)
Conditions: Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs
Interventions: Procedure: Oropharyngeal Cancer Screening;   Procedure: Ultrasound Scans;   Procedure: Anal Cancer Screening;   Procedure: High-Resolution Anoscopy (HRA);   Procedure: Penile Cancer Screening
4 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
5 Not yet recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
6 Active, not recruiting Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
Conditions: Penile Cancer;   Squamous Carcinoma
Intervention: Drug: Chemotherapie TIP
7 Not yet recruiting International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Condition: Squamous Cell Carcinoma of the Penis, Usual Type
Interventions: Procedure: ILND - Inguinal Lymph Node Dissection;   Drug: Paclitaxel;   Drug: Ifosfamide;   Drug: Cisplatin;   Radiation: Intensity modulated radiation treatment (IMRT);   Procedure: Prophylactic PLND - pelvic lymph node dissection
8 Completed T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Conditions: Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: Aldesleukin
9 Recruiting Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]
Condition: Squamous Cell Carcinoma of the Penis
Intervention: Procedure: MRI-PET
10 Withdrawn Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
Condition: Squamous Cell Carcinoma of the Penis
Interventions: Drug: Cetuximab;   Drug: TIP
11 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis and High Risk Individuals.
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma
Intervention:
12 Completed Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Oropharyngeal Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer
Interventions: Drug: Fludarabine;   Drug: Cycolphosphamide;   Biological: Young TIL;   Drug: Aldesleukin
13 Completed
Has Results
Cancer in Patients With Gabapentin (GPRD)
Conditions: Pain, Neuropathic;   Epilepsy;   Renal Pelvis Cancer;   Pancreatic Cancer;   Breast Cancer;   Nervous System Cancer;   Chronic Pancreatitis;   Stomach Cancer;   Renal Cell Carcinoma;   Diabetes;   Bladder Cancer;   Bone and Joint Cancer;   Penis Cancer;   Anal Cancer;   Cancer;   Renal Cancer
Intervention: Drug: Gabapentin prescriptions
14 Active, not recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
15 Active, not recruiting Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
Conditions: Penile Cancer;   Erectile Dysfunction;   Radical Prostatectomy
Interventions: Drug: Placebo QHS and sildenafil and questionnaires;   Drug: Sildenafil and questionnaire;   Drug: Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires
16 Completed
Has Results
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
Condition: Penile Cancer
Interventions: Drug: Ifosfamide;   Drug: Paclitaxel (Taxol);   Drug: Cisplatin
17 Completed Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
Condition: Penile Cancer
Interventions: Drug: cisplatin;   Drug: irinotecan hydrochloride;   Procedure: neoadjuvant therapy
18 Terminated S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
Condition: Penile Cancer
Intervention: Drug: docetaxel
19 Completed Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Conditions: Anal Cancer;   Cervical Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Penile Cancer;   Vulvar Cancer
Interventions: Biological: human papillomavirus 16 E7 peptide;   Biological: synthetic human papillomavirus 16 E6 peptide
20 Completed Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Conditions: Cervical Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Non-melanomatous Skin Cancer;   Penile Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: isotretinoin

Indicates status has not been verified in more than two years